JMP Securities Initiated Coverage on Chelsea Therapeutics and SolarWinds
December 19, 2013 at 15:58 PM EST
JMP Securities initiated coverage on Chelsea Therapeutics International (NASDAQ: CHTP ) and SolarWinds (NYSE: SWI ) with a Market Outperform rating in JMP's morning note published Thursday. Analyst Jason Butler initiated coverage on Chelsea Therapeutics with a Market Outperform rating and $8.00 price target. This development-stage biopharmaceutical
